Concepedia

Nathan A. Brooks

NA

21

Publications

856

Citations

16

H-Index

2009

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Iowa

Moffitt Cancer Center

University of Arizona

Levine Cancer Institute

Nathan A. Brooks is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, urology, and urogynecology.

Top concepts

MedicineUrologyUrogynecologySurgeryOncologyPathologyLaparoscopyBiochemistryPharmacologyDrug Discovery

Publications per year

2009–2022

21

Publications

21

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer

Ryan L. Steinberg, Lewis J. Thomas, Nathan A. Brooks et al. · The Journal of Urology · 2019 · 174 citations

Characterization of LY2228820 Dimesylate, a Potent and Selective Inhibitor of p38 MAPK with Antitumor Activity

Robert M. Campbell, Bryan D. Anderson, Nathan A. Brooks et al. · Molecular Cancer Therapeutics · 2013 · 115 citations

Drug Target, Antitumor Activity, P38 Mapk +20

Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors

Zhigang Wang, William Watt, Nathan A. Brooks et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2010 · 67 citations

Medicinal Chemistry, Caspase-8 Inhibition, Biochemistry +8

Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guérin: Implications for Clinical Trial Design

Justin T. Matulay, Roger Li, Patrick J. Hensley et al. · The Journal of Urology · 2021 · 64 citations

IRAK4 Kinase Activity Is Required for Th17 Differentiation and Th17-Mediated Disease

Kirk A. Staschke, Sucai Dong, J. K. Saha et al. · The Journal of Immunology · 2009 · 54 citations · Full text

Rows per page

1–5 of 21